Why a Theranostics No-Show Hurts Differently Than an IMRT One episode artwork

EPISODE · Jun 3, 2026 · 1 MIN

Why a Theranostics No-Show Hurts Differently Than an IMRT One

from Medsolve Dynamics · host Medsolve Dynamics

In radiation oncology, a curative no-show is a slot you backfill. In theranostics, the Lu-177 dose is a fixed amount with about a five-day shelf life, scheduled for one patient, and it cannot wait for a better day. Here is how scheduling discipline, authorized user coverage, and capture mechanics determine whether a theranostics service line holds its margin, and the two operating costs the vendor proforma leaves out. medsolvedynamics.com | [email protected]  #Theranostics #RadiationOncology #RadiopharmaceuticalTherapy #OncologyOperations

Episode metadata supplied by the publisher feed · Published Jun 3, 2026

Embed this episode

NOW PLAYING

Why a Theranostics No-Show Hurts Differently Than an IMRT One

0:00 1:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medsolve Dynamics?

This episode is 1 minute long.

When was this Medsolve Dynamics episode published?

This episode was published on June 3, 2026.

Can I download this Medsolve Dynamics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!